People

Tim Garnett
Tim Garnett is listed by Cambridge Innovation Capital as advisory panel member. Former Eli Lilly chief medical officer from 2008 to 2021, with clinical-development, pharmacovigilance and regulatory experience; trained in medicine and obstetrics/gynaecology. This affiliation follows CIC’s published directory; other career appointments are scoped to its biography and do not imply personal investment tickets.
Roles
Cambridge Innovation Capital
CurrentAdvisory Panel Member